A Phase 2 Open-label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women With Recurrent or Persistent Uterine Serous Carcinoma

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Setsuko Chambers
Sponsor
GOG Foundation, Inc.
Unit
Cancer Center Division